26B. Computational biology: Molecular simulation

[3Pos205] Development of antibodies with broadly binding affinity to SARS-CoV-2 variants in silico and in vitro assays

〇Xu Pan¹, Takashi Tadokoro^1,3, Yuki Anraku¹, Cong Tian¹, Hideo Fukuhara^1,2, Takao Nomura¹, Shunsuke Kita¹, Taishi Onodera⁴, Yu Adachi⁴, Saya Moriyama⁴, Kohei Yumoto⁴, Tateki Suzuki⁵, Jiei Sasaki⁵, Takao Hashiguchi⁵, Yoshimasa Takahashi⁴, Hisham M. Dokainish¹, Katsumi Maenaka¹ (1.Faculty of Pharmaceutical Sciences, Hokkaido University, 2.International Institute for Zoonosis Control, Hokkaido University, 3.Sanyo-Onoda City University, 4.National Institute of Infectious Diseases, 5.Laboratory of Medical Virology, Institute for Frontier Life and Medical Sciences, Kyoto University)